SOTAC PHARMACEUTICALS
Back to Income Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹2.88 Cr | ₹2.88 Cr | ₹-2.37 Cr | ₹0.09 Cr | ₹0.09 Cr |
What is the latest Consolidated Net Profit of SOTAC PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹2.88 Cr |
Mar2023 | ₹2.88 Cr |
Mar2022 | ₹-2.37 Cr |
Mar2021 | ₹0.09 Cr |
Mar2020 | ₹0.09 Cr |
How is Consolidated Net Profit of SOTAC PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹2.88 Cr | 0.03 | |
Mar2023 | ₹2.88 Cr | Positive | |
Mar2022 | ₹-2.37 Cr | Negative | |
Mar2021 | ₹0.09 Cr | 0.00 | |
Mar2020 | ₹0.09 Cr | - |
Compare Consolidated Net Profit of peers of SOTAC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOTAC PHARMACEUTICALS | ₹121.5 Cr | -1.1% | -20% | -8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
SOTAC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOTAC PHARMACEUTICALS | -1.1% |
-20% |
-8.1% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses